| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 08/29/2000 | US6110721 Isolated polypeptide at least about 80% homologous to and possesses at least one immune epitope of thrombin reference amino acid sequence; anticoagulants and procoagulants; diagnosis of blood disorders; drug screening; antitumor agents |
| 08/29/2000 | US6110706 Amino acid sequences; for increased immunogenicity |
| 08/29/2000 | US6110701 DNA encoding precursor of interleukin-1β converting enzyme--related cysteine proteinase II (ICErel -II) |
| 08/29/2000 | US6110700 Nucleic acids that code a modulator of kinase activity; for the diagnosis tumorous condition; for development of models for the evaluation cancer in organ and tissues |
| 08/29/2000 | US6110694 Methods for determining complexes of tumor rejection antigens and HLA-Cw*160/molecules |
| 08/29/2000 | US6110686 DNA hybridizing to a human cystatin-like protein (CSTIN) |
| 08/29/2000 | US6110675 Reagents and methods useful for detecting diseases of the prostate |
| 08/29/2000 | US6110672 Peripheral nervous system specific sodium channels, DNA encoding therefor, crystallization, X-ray diffraction, computer molecular modeling, rational drug design, drug screening, and methods of making and using thereof |
| 08/29/2000 | US6110487 Method of making porous keratin scaffolds and products of same |
| 08/29/2000 | US6110466 Modified plant viruses as vectors |
| 08/29/2000 | US6110464 Polypeptides with amino acid sequences |
| 08/29/2000 | US6110463 Anti-Cryptosporidium parvum preparations |
| 08/29/2000 | US6110460 Methods of using morphogen analogs |
| 08/29/2000 | US6110459 Grafting of myocardium tissues |
| 08/29/2000 | US6110458 Cancer therapy utilizing ex vivo gene transduction |
| 08/29/2000 | US6110208 Artificial skin containing as support biocompatible materials based on hyaluronic acid derivatives |
| 08/29/2000 | CA2010275C Pancreatic islet cell antigens obtained by molecular cloning |
| 08/29/2000 | CA1341090C Vampire bat plasminogen activators |
| 08/26/2000 | CA2296792A1 Expressed sequence tags and encoded human proteins |
| 08/25/2000 | CA2300692A1 Sequence-determined dna fragments and corresponding polypeptides encoded thereby |
| 08/24/2000 | WO2000049168A2 Helper adenovirus / helper-dependent adenovirus vector system based on site-specific recombinase activity |
| 08/24/2000 | WO2000049166A2 Production of helper dependent adenovirus vectors based on use of endonucleases |
| 08/24/2000 | WO2000049164A1 Dna encoding a plant lipase, transgenic plants and a method for controlling senescence in plants |
| 08/24/2000 | WO2000049162A2 Compositions and methods for non-targeted activation of endogenous genes |
| 08/24/2000 | WO2000049153A1 Fucosyl transferase gene |
| 08/24/2000 | WO2000049150A1 Chimeric gene constructs for generation of fluorescent transgenic ornamental fish |
| 08/24/2000 | WO2000049147A1 Hormone-hormone receptor complexes and nucleic acid constructs and their use in gene therapy |
| 08/24/2000 | WO2000049144A2 Pyk2 binding proteins |
| 08/24/2000 | WO2000049141A2 A method for production and delivery of a protein in vivo |
| 08/24/2000 | WO2000049138A2 Pluripotential cells derived from embryonal teratocarcinoma cells and the nucleus of stomatic cells |
| 08/24/2000 | WO2000049137A2 Pluripotential cell derived from an embryonic stem cell and a nucleus of a somatic cell |
| 08/24/2000 | WO2000049136A1 Genetically altered mesenchymal stem cells and methods of use thereof |
| 08/24/2000 | WO2000049135A2 Substrate for cell growth |
| 08/24/2000 | WO2000049043A2 Human lipid-associated proteins |
| 08/24/2000 | WO2000049040A2 Antimicrobial/endotoxin neutralizing polypeptide |
| 08/24/2000 | WO2000049039A2 Glucose dehydrogenase fusion proteins and their utilization in expression systems |
| 08/24/2000 | WO2000048642A2 Biocompatible material with a novel functionality |
| 08/24/2000 | WO2000048638A2 Multi-mutant diphtheria toxin vaccines |
| 08/24/2000 | WO2000048632A1 Novel redox clamping agents and uses thereof |
| 08/24/2000 | WO2000048631A2 Adjuvant and cell maturation agent |
| 08/24/2000 | WO2000048627A1 Inhibitors of separin, method for identifying them and uses |
| 08/24/2000 | WO2000048621A2 Methods and compositions for regulating protein-protein interactions |
| 08/24/2000 | WO2000048620A1 Yeast cell wall peptides and antibodies thereto |
| 08/24/2000 | WO2000048614A2 Method for producing anti-tumor th1 cells |
| 08/24/2000 | WO2000048462A1 Method for inhibiting transplant rejection |
| 08/24/2000 | WO2000031126A3 Suppression of xenotransplant rejection |
| 08/24/2000 | WO2000029554A3 Compositions for preserving haptenized tumor cells for use in vaccines |
| 08/24/2000 | WO2000029550A3 Low oxygen culturing of central nervous system progenitor cells |
| 08/24/2000 | WO2000023571A3 A method for isolating and purifying oligodendrocytes and oligodendrocyte progenitor cells |
| 08/24/2000 | WO2000023100A9 Genes and proteins predictive and therapeutic for renal disease and associated disorders |
| 08/24/2000 | WO2000022167A9 Method for determining transcription factor activity and its technical uses |
| 08/24/2000 | WO2000022113A9 ENZYMATIC SYNTHESIS OF ssDNA |
| 08/24/2000 | WO2000022112A9 Stabilized bioactive peptides and methods of identification, synthesis and use |
| 08/24/2000 | WO2000022096A9 Chinese hamster ovary cells for producing proteins |
| 08/24/2000 | WO2000021987A9 A method of identifying modulators of cell surface membrane receptors useful in the treatment of disease |
| 08/24/2000 | WO2000020434A9 Cadherin-like asymmetry protein-1, and methods for its use |
| 08/24/2000 | WO2000020025A9 Akt compositions for enhancing survival of cells |
| 08/24/2000 | WO2000016818A9 Functionalized derivatives of hyaluronic acid and formation of hydrogels in situ using same |
| 08/24/2000 | WO2000015796A3 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 08/24/2000 | WO2000015772A9 Recombinant protein production in urine |
| 08/24/2000 | WO2000015246A9 Regulation of lung tissue by hedgehog-like polypeptides, and formulations and uses related thereto |
| 08/24/2000 | WO2000012685A3 Genes associated with neurotransmitter processing |
| 08/24/2000 | WO2000005390A3 Controlling starch synthesis |
| 08/24/2000 | WO2000003002A3 Pure and viable human epithelial cell preparations from digestive tissue |
| 08/24/2000 | WO1998024898A3 Therapeutic composition comprising the kal protein and use of the kal protein |
| 08/24/2000 | DE4193302C2 Verwendung rekombinanter Antikörper spezifisch für TNF-alpha Using recombinant antibody specific for TNF-alpha |
| 08/24/2000 | DE19906744A1 Pharmaceutical composition useful for tumor therapy comprises tumor-reactive helper T cells that produce high levels of interferon gamma and little or no interleukin-4 |
| 08/24/2000 | DE19857692C1 Verfahren und Vorrichtung zur zellspurbasierten Zelluntersuchung Method and apparatus for cell-cell track-based investigation |
| 08/24/2000 | CA2371872A1 Methods and compositions for regulating protein-protein interactions |
| 08/24/2000 | CA2371799A1 Yeast cell wall peptides and antibodies thereto |
| 08/24/2000 | CA2368461A1 Glucose dehydrogenase fusion proteins and their utilization in expression systems |
| 08/24/2000 | CA2364267A1 Compositions and methods for non-targeted activation of endogenous genes |
| 08/24/2000 | CA2363063A1 Helper dependent adenovirus vectors based on site-specific recombinases |
| 08/24/2000 | CA2363061A1 Production of helper dependent adenovirus vectors based on use of endonucleases |
| 08/24/2000 | CA2362970A1 Hormone-hormone receptor complexes and nucleic acid constructs and their use in gene therapy |
| 08/24/2000 | CA2362943A1 Pyk2 binding proteins |
| 08/24/2000 | CA2362807A1 Multi-mutant diphtheria toxin vaccines |
| 08/24/2000 | CA2362787A1 Novel redox clamping agents and uses thereof |
| 08/24/2000 | CA2362538A1 Secreted proteins and polynucleotides encoding them |
| 08/24/2000 | CA2362300A1 Human lipid-associated proteins |
| 08/24/2000 | CA2362161A1 Method for inhibiting transplant rejection |
| 08/24/2000 | CA2296782A1 Downstream genes of tumor suppressor wt1 |
| 08/24/2000 | CA2262056A1 Composition, methods and reagents for the synthesis of a soluble form of human pex |
| 08/23/2000 | EP1029923A1 Method for conveying BNYVV resistance to sugar beet plants |
| 08/23/2000 | EP1029870A2 Hybrid Immunoglobulins |
| 08/23/2000 | EP1029547A1 Pharmaceutically active compounds and method for identifying same |
| 08/23/2000 | EP1029081A1 Methods and compositions for peptide libraries displayed on light-emitting scaffolds |
| 08/23/2000 | EP1029068A2 Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis |
| 08/23/2000 | EP1029067A1 Nucleic acid molecules which encode proteins having fructosyl transferase activity and methods for producing long-chain inulin |
| 08/23/2000 | EP1029065A1 Gene coding for thanatin, vector containing same and resulting transformed disease-resistant plants |
| 08/23/2000 | EP1029062A1 Inhibition of human immunodeficiency virus (hiv-1) replication |
| 08/23/2000 | EP1029060A1 Chimeric hydroxy-phenyl pyruvate dioxygenase, dna sequence and method for obtaining plants containing such a gene, with herbicide tolerance |
| 08/23/2000 | EP1029059A1 Mutated hydroxy-phenyl pyruvate dioxygenase, dna sequence and method for obtaining herbicide-tolerant plants containing such gene |
| 08/23/2000 | EP1029057A1 Reovirus-derived proteins, nucleic acids encoding same, and uses therefor |
| 08/23/2000 | EP1029056A2 Plant-optimized genes encoding pesticidal toxins |
| 08/23/2000 | EP1029054A1 Hp90: host membrane receptor for pathogenic bacteria, encoded by the bacterial tir gene |
| 08/23/2000 | EP1029051A1 Genes with restricted expression in mesencephalic dopaminergic neurons |
| 08/23/2000 | EP1029049A2 Bmog, a protein member of the myelin-oligodendrocyte glycoprotein family and its use |
| 08/23/2000 | EP1029046A2 Wnt-1 inducible genes |
| 08/23/2000 | EP1029045A2 EXTENDED cDNAs FOR SECRETED PROTEINS |